UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact name of Company as specified in its charter)
|
|
|
(State or Other Jurisdiction | (Commission File Number) | (IRS Employer |
of Incorporation) |
| Identification Number) |
| (Address of Principal Executive Offices)
( (Registrant’s Telephone Number) |
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing
obligation of the Company under any of the following provisions:
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbols(s) | Name of each exchange on which registered |
N/A |
|
|
Page 1
FORWARD LOOKING STATEMENTS
The following discussion, in addition to the other information contained in this Current Report, should be considered carefully in evaluating our prospects. This Report (including without limitation the following factors that may affect operating results) contains forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (“Exchange Act”) regarding us and our business, financial condition, results of operations and prospects. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements but are not the exclusive means of identifying forward-looking statements in this Report. Additionally, statements concerning future matters such as revenue projections, projected profitability, growth strategies, possible changes in legislation and other statements regarding matters that are not historical are forward-looking statements.
ADDITIONAL INFORMATION
You are urged to read this Current Report carefully. This Current Report is not all-inclusive and does not contain all the information that you may desire in evaluating the Company. You must conduct and rely on your own evaluation of the Company, including the merits and risks involved in making a decision to invest in our stock. No representations or warranties of any kind are intended nor should any be inferred with respect to the economic viability of the Company or with respect to any benefits, which may accrue as a result of an investment in the Company. The Company does not in any way represent, guarantee or warrant an economic gain or profit with regard to our business. We do not in any way represent or warrant the advisability of investing in our stock. Any projections, forecasts, or other forward-looking statements or opinions contained in this Current Report constitute estimates by us based upon sources deemed to be reliable, but the accuracy of this information is not guaranteed nor should you consider the information all-inclusive.
As used in this Current Report and unless otherwise indicated, the terms “we,” “us,” “our,” the “Company,” and “Bakhu” refer to Bakhu Holdings Corp.
Item 1.01Entry into a Material Definitive Agreements.
Consulting Agreements
On July 28, 2021 the Company entered into a Consulting Agreements with each of Damian Solomon and Sean Akhavan (individually a “Consultant” and collectively the “Consultants”). The Consultants shall work with the Company’s science team in the development potential products which sublicensees might manufacture from the dry cell concentrate that is produced utilizing the Company’s Licensed Science. The term of the Consulting Agreements is 90 days, commencing on August 7, 2021 (the “Commencement Date”). Pursuant to the Consulting Agreements, in consideration for certain advisory services rendered by the Consultant, the Company granted each Consultant a non-qualified Stock Option (the “Option”) to purchase 100,000 shares of Common Stock at an exercise price of $4.20, representing the closing price of the Common Stock, as report on the OTC Markets, on July 27, 2021. The Options shall vest, subject to the Consultants’ continued services with the Company under the Consulting Agreement, 90 days after the Commencement Date.
The foregoing summary descriptions of the terms of the Consulting Agreements is a summary only and does not purport to be complete, may not contain all information that is of interest to the reader and is qualified in its entirety by reference to the full text of the Consulting Agreements, attached hereto as Exhibits 10.01 and 10.02.
Item 3.01 Unregistered Sale of Equity Securities
On July 30, 2021, the Company issued 16,667 restricted shares of Common Stock to an accredited investor for cash at $3.00 per share for aggregate consideration of $50,001. No underwriters were involved in the transaction. The shares were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933.
Page 2
Item 9.01 Financial Statements and Exhibits
(d) Exhibits. The following exhibits are either filed as a part hereof or are incorporated by reference. Exhibit numbers correspond to the numbering system in Item 601 of Regulation S-K.
Exhibit |
|
Number | Description of Exhibit |
10.1 | Consulting Agreement with Damian Solomon dated July 28, 2021(1) |
10.2 | Consulting Agreement with Sean Akhavan dated July 28, 2021(1) |
(1) Filed herewith
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
| BAKHU HOLDINGS CORP. |
|
|
|
Date: August 2, 2021 |
|
/S/ Thomas K Emmitt |
|
| By: Thomas K. Emmitt Its: President and Chief Executive Officer (Principal Executive Officer) |
Page 3